(YOU) Clear Secure - Overview
Stock: Identity, Verification, Subscription, App, Queuing
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.66% |
| Yield on Cost 5y | 1.38% |
| Yield CAGR 5y | 25.99% |
| Payout Consistency | 90.6% |
| Payout Ratio | 49.9% |
| Risk 5d forecast | |
|---|---|
| Volatility | 44.5% |
| Relative Tail Risk | -7.43% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.02 |
| Alpha | 36.56 |
| Character TTM | |
|---|---|
| Beta | 0.733 |
| Beta Downside | 0.420 |
| Drawdowns 3y | |
|---|---|
| Max DD | 45.69% |
| CAGR/Max DD | 0.18 |
Description: YOU Clear Secure January 10, 2026
Clear Secure, Inc. (NYSE:YOU) runs the CLEAR brand, a U.S.-focused secure-identity platform that blends front-end enrollment, biometric verification, and back-end data linking to speed travelers through airport security and other high-traffic venues.
Beyond its core B2C offering (CLEAR Plus and the CLEAR mobile app), the firm monetizes ancillary services such as RESERVE (airport reservation slots), Home to Gate (trip-timing assistance), CLEAR1 (B2B identity-as-a-service), TSA PreCheck enrollment, and Sora ID for KYC compliance, all of which are delivered via a virtual-queue technology stack.
Recent metrics show FY 2023 revenue of roughly $460 million, up ~22% YoY, with a 71% gross margin reflecting the high-margin software nature of the business; the company’s subscriber base grew to ~12 million members, driven by a rebound in U.S. air travel demand and airlines’ increasing willingness to embed biometric solutions. The broader application-software sector is benefitting from a 9% CAGR in enterprise identity-verification spend, while macro-level travel recovery and heightened security regulations remain key growth catalysts.
Analysts should keep an eye on the scalability of CLEAR1 partnerships and the potential impact of privacy-regulation changes, as these could materially affect future cash-flow trajectories.
For a deeper quantitative dive, you might explore ValueRay’s detailed valuation models for YOU.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 181.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.26 > 0.02 and ΔFCF/TA -2.16 > 1.0 |
| NWC/Revenue: -5.04% < 20% (prev 5.18%; Δ -10.21% < -1%) |
| CFO/TA 0.28 > 3% & CFO 310.6m > Net Income 181.7m |
| Net Debt (-75.8m) to EBITDA (199.2m): -0.38 < 3 |
| Current Ratio: 0.93 > 1.5 & < 3 |
| Outstanding Shares: last quarter (97.8m) vs 12m ago 3.77% < -2% |
| Gross Margin: 63.58% > 18% (prev 0.63%; Δ 6295 % > 0.5%) |
| Asset Turnover: 87.31% > 50% (prev 85.63%; Δ 1.69% > 0%) |
| Interest Coverage Ratio: 2.33 > 6 (EBITDA TTM 199.2m / Interest Expense TTM 74.9m) |
Altman Z'' 1.34
| A: -0.04 (Total Current Assets 589.0m - Total Current Liabilities 632.7m) / Total Assets 1.13b |
| B: 0.09 (Retained Earnings 101.2m / Total Assets 1.13b) |
| C: 0.18 (EBIT TTM 174.9m / Avg Total Assets 992.2m) |
| D: 0.11 (Book Value of Equity 102.1m / Total Liabilities 959.7m) |
| Altman-Z'' Score: 1.34 = BB |
Beneish M -0.82
| DSRI: 2.17 (Receivables 1.63m/639.0k, Revenue 866.3m/735.2m) |
| GMI: 1.00 (GM 63.58% / 63.36%) |
| AQI: 3.08 (AQ_t 0.34 / AQ_t-1 0.11) |
| SGI: 1.18 (Revenue 866.3m / 735.2m) |
| TATA: -0.11 (NI 181.7m - CFO 310.6m) / TA 1.13b) |
| Beneish M-Score: -0.82 (Cap -4..+1) = D |
What is the price of YOU shares?
Over the past week, the price has changed by +3.49%, over one month by -6.04%, over three months by +5.81% and over the past year by +48.53%.
Is YOU a buy, sell or hold?
- StrongBuy: 1
- Buy: 2
- Hold: 4
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the YOU price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 39.4 | 16.6% |
| Analysts Target Price | 39.4 | 16.6% |
| ValueRay Target Price | 37.2 | 10.3% |
YOU Fundamental Data Overview February 07, 2026
P/S = 5.0722
P/B = 20.9168
Revenue TTM = 866.3m USD
EBIT TTM = 174.9m USD
EBITDA TTM = 199.2m USD
Long Term Debt = 113.7m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 6.16m USD (from shortTermDebt, last fiscal year)
Debt = 121.3m USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -75.8m USD (from netDebt column, last quarter)
Enterprise Value = 4.44b USD (4.39b + Debt 121.3m - CCE 75.8m)
Interest Coverage Ratio = 2.33 (Ebit TTM 174.9m / Interest Expense TTM 74.9m)
EV/FCF = 15.33x (Enterprise Value 4.44b / FCF TTM 289.6m)
FCF Yield = 6.52% (FCF TTM 289.6m / Enterprise Value 4.44b)
FCF Margin = 33.43% (FCF TTM 289.6m / Revenue TTM 866.3m)
Net Margin = 20.97% (Net Income TTM 181.7m / Revenue TTM 866.3m)
Gross Margin = 63.58% ((Revenue TTM 866.3m - Cost of Revenue TTM 315.5m) / Revenue TTM)
Gross Margin QoQ = 65.35% (prev 64.05%)
Tobins Q-Ratio = 3.94 (Enterprise Value 4.44b / Total Assets 1.13b)
Interest Expense / Debt = 6.23% (Interest Expense 7.55m / Debt 121.3m)
Taxrate = 25.84% (15.7m / 60.9m)
NOPAT = 129.7m (EBIT 174.9m * (1 - 25.84%))
Current Ratio = 0.93 (Total Current Assets 589.0m / Total Current Liabilities 632.7m)
Debt / Equity = 0.82 (Debt 121.3m / totalStockholderEquity, last quarter 148.6m)
Debt / EBITDA = -0.38 (Net Debt -75.8m / EBITDA 199.2m)
Debt / FCF = -0.26 (Net Debt -75.8m / FCF TTM 289.6m)
Total Stockholder Equity = 146.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 18.31% (Net Income 181.7m / Total Assets 1.13b)
RoE = 124.2% (Net Income TTM 181.7m / Total Stockholder Equity 146.2m)
RoCE = 67.30% (EBIT 174.9m / Capital Employed (Equity 146.2m + L.T.Debt 113.7m))
RoIC = 88.70% (NOPAT 129.7m / Invested Capital 146.2m)
WACC = 8.50% (E(4.39b)/V(4.52b) * Re(8.61%) + D(121.3m)/V(4.52b) * Rd(6.23%) * (1-Tc(0.26)))
Discount Rate = 8.61% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 3.48%
[DCF Debug] Terminal Value 79.64% ; FCFF base≈269.5m ; Y1≈332.5m ; Y5≈566.2m
Fair Price DCF = 89.89 (EV 8.68b - Net Debt -75.8m = Equity 8.76b / Shares 97.4m; r=8.50% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 55.83 | EPS CAGR: 9.08% | SUE: -1.37 | # QB: 0
Revenue Correlation: 97.07 | Revenue CAGR: 32.11% | SUE: 3.37 | # QB: 12
EPS next Quarter (2026-03-31): EPS=0.39 | Chg30d=+0.007 | Revisions Net=-2 | Analysts=4
EPS next Year (2026-12-31): EPS=1.87 | Chg30d=+0.181 | Revisions Net=+1 | Growth EPS=+24.0% | Growth Revenue=+12.7%